Linopirdine
CAS No. 105431-72-9
Linopirdine( DUP-996 | Linopirine )
Catalog No. M10251 CAS No. 105431-72-9
Linopirdine (DUP-996;Linopirine) is a potent Kv7 (KCNQ) voltage-gated potassium channels blcoker; blocks KV7.1+7.3 (KCNQ2+3)/M-currents (IC50=4-7 uM) and KV7.1 (KCNQ1) homomeric channels (IC50=8.9 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 46 | Get Quote |
|
| 5MG | 72 | Get Quote |
|
| 10MG | 115 | Get Quote |
|
| 25MG | 215 | Get Quote |
|
| 50MG | 372 | Get Quote |
|
| 100MG | 531 | Get Quote |
|
| 200MG | 768 | Get Quote |
|
| 500MG | 1143 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLinopirdine
-
NoteResearch use only, not for human use.
-
Brief DescriptionLinopirdine (DUP-996;Linopirine) is a potent Kv7 (KCNQ) voltage-gated potassium channels blcoker; blocks KV7.1+7.3 (KCNQ2+3)/M-currents (IC50=4-7 uM) and KV7.1 (KCNQ1) homomeric channels (IC50=8.9 uM).
-
DescriptionLinopirdine (DUP-996;Linopirine) is a potent Kv7 (KCNQ) voltage-gated potassium channels blcoker; blocks KV7.1+7.3 (KCNQ2+3)/M-currents (IC50=4-7 uM) and KV7.1 (KCNQ1) homomeric channels (IC50=8.9 uM); inhibits M-type K+ current, increases acetylcholine release in rat hippocampal CA1 neurons; active in vivo.Alzheimer Disease Phase 1 Discontinued.
-
In Vitro——
-
In VivoAnimal Model:Male Sprague-Dawley rats (300-350 g)Dosage:0.1, 0.5, 1, 3, 6 mg/kg Administration:5 intravenous bolus injections of increasing dosesResult:Transiently and dose-dependently increases MAP by up to 15%.
-
SynonymsDUP-996 | Linopirine
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorPotassium Channel
-
Research AreaNeurological Disease
-
IndicationAlzheimer Disease
Chemical Information
-
CAS Number105431-72-9
-
Formula Weight391.465
-
Molecular FormulaC26H21N3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (319.32 mM)
-
SMILESO=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5
-
Chemical Name1,3-Dihydro-1-phenyl-3,3-bis(4-pyridinylmethyl)-2H-indol-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
OR-1896
OR-1896 is the active metabolite of Levosimendan, a highly specific phosphodiesterase (PDE III) inhibitor, a vasodilator with partial anti-inflammatory properties that produces vasodilation in different types of blood vessels through activation of ATP-sensitive (KATP) and other potassium channels.
-
5-Hydroxydecanoate s...
5-Hydroxydecanoate sodium is a selective ATP-sensitive K+ (KATP) channel blocker with an IC50 of approximately 30 μM and a substrate for mitochondrial outer membrane acyl-CoA synthetase, possessing antioxidant properties.
-
KCNQ1 activator-1?
2-Piperidinecarboxamide, N-[4-(4-methoxyphenyl)-2-thiazolyl]-1-(phenylsulfonyl)- is a potent KCNQ1 channel activator that can be used in long QT syndrome (LQTS) studies.
Cart
sales@molnova.com